CDLX CARDLYTICS INC

Ownership history in RBF Capital, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which RBF Capital, LLC reported a position in CARDLYTICS INC (CDLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.15% (2024 Q4)
Avg. % of fund
0.08%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 800,103 0% 0.04% $920K $1.15
2025 Q3 REDUCED 800,103 -28,660 -3.5% 0.09% $1.9M $2.43
2025 Q2 UNCHANGED 828,763 0% 0.06% $1.4M $1.64
2025 Q1 ADDED 828,763 +25,000 +3.1% 0.09% $1.5M $1.82
2024 Q4 ADDED 803,763 +315,635 +64.7% 0.15% $3.0M $3.71
2024 Q3 ADDED 488,128 +369,620 +311.9% 0.08% $1.6M $3.20
2024 Q2 ADDED 118,508 +3,508 +3.1% 0.06% $973K $8.21
2024 Q1 INITIATED 115,000 0.09% $1.7M
% of Fund (quarterly)    CDLX price (monthly, adj. close)
← Back to RBF Capital, LLC Holdings